Needle and syringe sharing practices among injecting drug users in Tehran: A comparison of two neighborhoods, one with and one without a needle and syringe program

AIDS and Behavior

Volumn 14, Issue 4, 2010, Pages 885-890

  Zamani, Saman ^a   Vazirian, Mohsen ^b   Nassirimanesh, Bijan ^c   Razzaghi, Emran Mohammad ^b   Ono Kihara, Masako ^a   Ravari, Shahrzad Mortazavi ^a   Gouya, Mohammad Mehdi ^d   Kihara, Masahiro ^a  

^a KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Persepolis Society   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

HIV; Iran; Needle exchange programs; Substance abuse, intravenous

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG ABUSE; DRUG USE; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; IRAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; STATISTICS; SUBSTANCE ABUSE; SYRINGE;

ADULT; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; IRAN; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION; RESIDENCE CHARACTERISTICS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; YOUNG ADULT;

EID: 77956873578     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-008-9404-2     Document Type: Article

References (25)

1. Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS, 14, 605-611. doi: 10.1097/00002030-200003310-00015 (Pubitemid 30209702)
2. Center for Disease Management. (2006). AIDS/HIV Surveillance Report from the Center for Disease Management, Ministry of Health and Medical Education, Iran. Tehran: Center for Disease Management.
3. Chen, H. T., & Liao, Q. (2005). Pilot study of the NGO-based relational intervention model for HIV prevention among drug users in China. AIDS Education and Prevention, 17, 503-514. doi:10.1521/aeap.2005.17.6.503. (Pubitemid 43061817)
4. Cox, G. M., Lawless, M. C., Cassin, S. P., & Geoghegan, T. W. (2000). Syringe exchanges: A public health response to problem drug use. Irish Medical Journal, 93, 143-146.
5. Gibson, D. R., Brand, R., Anderson, K., Kahn, J. G., Perales, D., & Guydish, J. (2002). Two-to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiency Syndromes, 31, 237-242.
6. Gray, J. (1998). Harm reduction in the hills of northern Thailand. Substance Use & Misuse, 33, 1075-1091.
7. Hartgers, C., Buning, E. C., van Santen, G. W., Verster, A. D., & Coutinho, R. A. (1989). The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS, 3, 571-576. doi:10.1097/ 00002030-198909000-00003.
8. Iran Prison Organization. (2006). An overview on HIV/AIDS in prisons of The Islamic Republic of Iran [In Persian] by Health and Treatment Headquarter. Tehran: Iran Prison Organization.
9. Latkin, C. A., Vlahov, D., & Anthony, J. C. (1993). Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction, 88, 517-526. doi: 10.1111/j.1360-0443.1993. tb02058.x.
10. Power, R., & Nozhkina, N. (2002). The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS, 16, 303-304. doi:10.1097/00002030-200201250-00028 (Pubitemid 34118585)
11. Quan, V. M., Chung, A., & Abdul-Quader, A. S. (1998). The feasibility of a syringe-needle-exchange program in Vietnam. Substance Use & Misuse, 33, 1055-1067.
12. Razzaghi, E., Nassirimanesh, B., Afshar, P., Ohiri, K., Claeson, M., & Power, R. (2006a). HIV/AIDS harm reduction in Iran. Lancet, 368, 434-435. doi:10.1016/S0140-6736(06)69132-0. (Pubitemid 44142754)
13. Razzaghi, E. M., & Rahimi, M. A. (2005). Injection drug use in Tehran. Tehran: Tehran University of Medical Sciences Press.
14. Razzaghi, E. M., Rahimi M. A., Green, T. C., & Khoshnood, K. (2006b). Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal, 3, article 12. Accessed 30 Oct 30 2007, at http://www.harmreductionjournal. com/content/3/1/12.
15. Razzaghi, E. M., Rahimi, M. A., Hoseini, M., Madani, S., & Mohammad, K. (2000). Rapid assessment of drug misuse in Iran, Tehran. Tehran: Iranian Welfare Organization Press.
16. Shrestha, S., Smith, M. W., Broman, K. W., Farzadegan, H., Vlahov, D., & Strathdee, S. A. (2006). Multiperson use of syringes among injection drug users in a needle exchange program: A gene-based molecular epidemiologic analysis. Journal of Acquired Immune Deficiency Syndromes, 43, 335-343. doi: 10.1097/01.qai.0000230528.25083.0b. (Pubitemid 44674015)
17. Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaugh-nessy, M. V., et al. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887-893. doi:10.1097/00002030-200304110-00014 (Pubitemid 36547661)
18. UNAIDS. (2007). Country situation analysis-Islamic Republic of Iran. Accessed 30 October 2007, at http://www.unaids.org/ en/Regions-Countries/ Countries/Iran-Islamic-Republic-of.asp.
19. Vazirian, M. (2003). Review of drug demand reduction programs in Iran: Advice for development and strategic planning [in Persian]. Social Welfare Quarterly, 9, 145-201.
20. Vazirian, M., De Kort, G., & Nassirimanesh, B. (2006). Young people and drugs-towards a comprehensive health promotion policy-Tehran report. Asian Harm Reduction Network, UNODC, Ministry of Health and Medical Education, Iran
21. Vazirian, M., Nassirimanesh, B., Zamani, S., Ono-Kihara, M., Kihara, M., Mortazavi Ravari, S., & Gouya, M. M. (2005). Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal, 2, article 19. Accessed 30 October 2007, at http://www.harmreductionjournal.com/ content/2/1/19.
22. WHO. (2004). Best practice in HIV/AIDS prevention and care for injecting drug abusers: The triangular clinic in Kermanshah, Islamic Republic of Iran. Cairo: Regional Office for the Eastern Mediterranean, World Health Organization. Accessed 30 October 2007, at http://www.emro.who.int/asd/PDF/STD-052.pdf.
23. Wodak, A., & Cooney, A. (2005). Effectiveness of sterile needle and syringe programmes. The International Journal of Drug Policy, 16, S31-S44. doi:10.1016/j.drugpo.2005.02.004. (Pubitemid 41735173)
24. Zamani, S., Kihara, M., Gouya, M. M., Vazirian, M., Nassirimanesh, B., Ono-Kihara, M., et al. (2006). High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndromes, 42, 342-346. doi:10.1097/01.qai. 0000219785.81163.67.
25. Zamani, S., Kihara, M., Gouya, M. M., Vazirian, M., Ono-Kihara, M., Razzaghi, E. M., et al. (2005). Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS, 19, 709-716. doi: 10.1097/01.aids.0000166094.24069.72.